RYAH Stock Overview
RYAH Group Inc., a technology company, provides personalized wellness ecosystem of IoT-connected medical devices, AI analytics, and big data to medical cannabis industry in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
RYAH Group, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.025 |
| 52 Week High | CA$0.12 |
| 52 Week Low | CA$0.015 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -73.68% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.50% |
Recent News & Updates
Recent updates
Shareholder Returns
| RYAH | CA Medical Equipment | CA Market | |
|---|---|---|---|
| 7D | 0% | 0.6% | 0.7% |
| 1Y | -73.7% | -25.7% | 5.5% |
Return vs Industry: RYAH underperformed the Canadian Medical Equipment industry which returned -6.5% over the past year.
Return vs Market: RYAH underperformed the Canadian Market which returned -0.7% over the past year.
Price Volatility
| RYAH volatility | |
|---|---|
| RYAH Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 11.4% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.2% |
| 10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: RYAH has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine RYAH's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Dave Richards | ryah.com |
RYAH Group, Inc., a big data and technology company, develops various Internet of Things products. It offers dose-control devices, such as RYAH Smart Patch that provides users with the ability to boost their patch for on-demand relief; RYAH Smart Inhaler, a dry herb inhaler with an integrated volumetric airflow sensor, which enable consumers to track and control how much they inhale; and RYAH Smart Pen, a multi-liquid chamber pen that dispense up to three different formulations at once for a dose controlled entourage effect. The company also provides RYAH MD, a platform for doctors to remotely monitor and control their patients’ dosing regimen with RYAH’s suite of dose-measuring products; and RYAH Cloud, a data engine that captures millions of points of structured and unstructured data, and analyze seed-to-consumer intelligence to enable doctors and clinics to create personalized therapies.
RYAH Group, Inc. Fundamentals Summary
| RYAH fundamental statistics | |
|---|---|
| Market cap | CA$14.76m |
| Earnings (TTM) | -CA$29.59m |
| Revenue (TTM) | CA$136.51k |
114.6x
P/S Ratio-0.5x
P/E RatioIs RYAH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RYAH income statement (TTM) | |
|---|---|
| Revenue | US$100.10k |
| Cost of Revenue | US$46.98k |
| Gross Profit | US$53.11k |
| Other Expenses | US$21.75m |
| Earnings | -US$21.70m |
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.037 |
| Gross Margin | 53.06% |
| Net Profit Margin | -21,674.89% |
| Debt/Equity Ratio | -65.5% |
How did RYAH perform over the long term?
See historical performance and comparison